RAC3 and hepatocellular carcinoma: Taken together, these findings imply that RAC3 may serve as a tumor promoter, driving hepatocarcinogenesis and the malignancy of HCC by activating the cAMP/MAPK/Rap1 signaling pathway through NNMT.